ES8602414A1 - Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide - Google Patents

Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide

Info

Publication number
ES8602414A1
ES8602414A1 ES532641A ES532641A ES8602414A1 ES 8602414 A1 ES8602414 A1 ES 8602414A1 ES 532641 A ES532641 A ES 532641A ES 532641 A ES532641 A ES 532641A ES 8602414 A1 ES8602414 A1 ES 8602414A1
Authority
ES
Spain
Prior art keywords
heparin
antithrombin iii
complex
iii
heparinoid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532641A
Other languages
English (en)
Other versions
ES532641A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of ES532641A0 publication Critical patent/ES532641A0/es
Publication of ES8602414A1 publication Critical patent/ES8602414A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN CONCENTRADO DE ANTITROMBINA III-HEPARINA O DE ANTITROMBINA III-HEPARINOIDE Y DE ANTITROMBINA III. CONSISTE EN MEZCLAR PLASMA HUMANO O FRACCIONES DE PLASMA QUE CONTIENEN ANTITROMBINA III CON FORMACION DE UN COMPLEJO DE ANTITROMBINA III-HEPARINOIDE CON HEPARINA O HEPARINOIDE. EL COMPLEJO FORMADO SE ADSORBE A UN INTERCAMBIADOR DE ANIONES, EL ADSORBATO SE ELUYE POR MEDIO DE UNA SOLUCION SALINA, SE ELIMINA DEL ELUATO SALES Y PROTEINAS INDESEABLES Y EL PRODUCTO OBTENIDO SE LLEVA A FORMA ESTABLE MEDIANTE LIOFILIZACION. PARA OBTENER ANTITROMBINA LIBRE SE TRATA LA SOLUCION QUE CONTIENE EL COMPLEJO CON PROTAMINA INMOVILIZADA, CON LO QUE SE DESDOBLA EL COMPLEJO Y SE FIJA LA HEPARINA A LA PROTAMINA INMOVILIZADA, LA PORCION SOBRENADANTE QUE CONTIENE LA ANTITROMBINA III SE LLEVA A FORMA ESTABLE POR LIOFILIZACION. APLICACION COMO ANTICOAGULANTE.
ES532641A 1983-05-20 1984-05-18 Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide Expired ES8602414A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0185983A AT379310B (de) 1983-05-20 1983-05-20 Verfahren zur herstellung eines antithrombin iii-heparin- bzw. antithrombin iii-heparinoidkonzentrates

Publications (2)

Publication Number Publication Date
ES532641A0 ES532641A0 (es) 1985-12-01
ES8602414A1 true ES8602414A1 (es) 1985-12-01

Family

ID=3522546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532641A Expired ES8602414A1 (es) 1983-05-20 1984-05-18 Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide

Country Status (8)

Country Link
US (1) US4510084A (es)
EP (2) EP0307002B1 (es)
JP (2) JPS59222421A (es)
AT (3) AT379310B (es)
CA (1) CA1211371A (es)
DE (2) DE3485288D1 (es)
DK (2) DK167271B1 (es)
ES (1) ES8602414A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58180162A (ja) * 1982-04-19 1983-10-21 株式会社高研 抗血栓性医用材料
US4820693A (en) * 1986-05-22 1989-04-11 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4966890A (en) * 1986-04-04 1990-10-30 Angiogenics, Ltd. Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
CA1341379C (en) * 1988-04-28 2002-07-23 Welfide Corporation Purified antithrombin-iii and methods of producing the same
JP2678249B2 (ja) * 1988-06-22 1997-11-17 株式会社ミドリ十字 アンチトロンビン−▲ｉｉｉ▼製剤
JP3711561B2 (ja) * 1993-04-05 2005-11-02 三菱ウェルファーマ株式会社 アンチトロンビン−▲ｉｉｉ▼液状製剤およびその安定化方法
JPH08199580A (ja) * 1995-01-24 1996-08-06 Tetra:Kk 斜面昇降装置
US6562781B1 (en) 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US7045585B2 (en) * 1995-11-30 2006-05-16 Hamilton Civic Hospital Research Development Inc. Methods of coating a device using anti-thrombin heparin
US6491965B1 (en) 1995-11-30 2002-12-10 Hamilton Civic Hospitals Research Development, Inc. Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
AT405739B (de) 1997-09-19 1999-11-25 Immuno Ag Verfahren zur reinigung von antithrombin iii
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3099600A (en) * 1961-01-26 1963-07-30 Ormonoterapia Richter Spa Chromatographic purification of heparin
SE392038B (sv) * 1971-09-08 1977-03-14 Kabi Ab Forfarande for isolering av antitrombin ur blod eller blodprodukter
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4119774A (en) * 1976-03-05 1978-10-10 Ab Kabi Heparin purification method
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4175182A (en) * 1978-07-03 1979-11-20 Research Corporation Separation of high-activity heparin by affinity chromatography on supported protamine
JPS6011922B2 (ja) * 1978-09-22 1985-03-29 天野製薬株式会社 高活性ヘパリンの製造法
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
FR2472390A1 (fr) * 1979-05-04 1981-07-03 Merieux Inst Procede de preparation de concentres de complexe prothrombinique hautement purifies, et concentres obtenus
GB2061687B (en) * 1979-11-02 1983-04-13 Kidd A W Grass cutting machines and improved blade therefor
DD148297A1 (de) * 1979-12-21 1981-05-20 Bezirks Inst Fuer Blutspende U Verfahren zur herstellung von prothrombinkomplexkonzentraten mit verminderter thrombogenizitaet
DE3036481A1 (de) * 1980-09-27 1982-05-19 EC Erdölchemie GmbH, 5000 Köln Verfahren zur gemeinsamen herstellung von c 4 -oligomeren und alkyl-tert.-butylethern
US4446126A (en) * 1980-09-30 1984-05-01 Cutter Laboratories, Inc. Antithrombin-heparin complex and method for its production

Also Published As

Publication number Publication date
DK168062B1 (da) 1994-01-31
JPH05320198A (ja) 1993-12-03
JPH053480B2 (es) 1993-01-14
DK241684A (da) 1984-11-21
DK167271B1 (da) 1993-10-04
EP0129534B1 (de) 1989-08-23
CA1211371A (en) 1986-09-16
ATE45747T1 (de) 1989-09-15
ATE69552T1 (de) 1991-12-15
DE3479503D1 (en) 1989-09-28
EP0129534A3 (en) 1985-12-04
DK292090D0 (da) 1990-12-07
ES532641A0 (es) 1985-12-01
ATA185983A (de) 1985-05-15
AT379310B (de) 1985-12-27
DK292090A (da) 1990-12-07
US4510084A (en) 1985-04-09
JPH07116235B2 (ja) 1995-12-13
EP0307002B1 (de) 1991-11-21
DK241684D0 (da) 1984-05-16
EP0307002A1 (de) 1989-03-15
DE3485288D1 (de) 1992-01-02
JPS59222421A (ja) 1984-12-14
EP0129534A2 (de) 1984-12-27

Similar Documents

Publication Publication Date Title
ES8602414A1 (es) Procedimiento para la preparacion de un concentrado de antitrombina iii-heparina o de antitrombina iii-heparinoide
EP0026970B1 (en) Process for recovering interferon
EP0121976A3 (en) Partially purified osteogenic factor and process for preparing same from demineralized bone or an osteosarcoma
PT85730A (en) Process for the preparation of megakaryocyte stimulatory factor
EP0011435A1 (en) Method of purification of human fibroblast interferon
US4597899A (en) Process for obtaining a factor XIII preparation, and its use
US2770616A (en) Fractionation of proteinaceous materials in blood plasma and liver tissue
BLOMBACK et al. Note on the Purification. of Human Antihemophilic Globulin
JPS5758629A (en) Separating and purifying method of colonization stimulating factor and callicrein in human urine
ES8405621A1 (es) Una inmunopreparacion tumoral.
GB1507215A (en) Processes for producing immunoregulatory preparations
FUNATSU et al. Structure and Toxic Function of Ricin I Purification Procedures of Ricin D
JP2613098B2 (ja) ラクトフェリンの噴霧乾燥法
ES423697A1 (es) Un procedimiento para preparar una solucion de haptoglobinade suero humano.
US3109774A (en) Erythropoietic factor preparation
GB1508922A (en) Method for obtaining urokinase
US2957807A (en) Process of preparing acth-active concentrates
SU1247379A1 (ru) Способ получени лейкоцитарного альфа @ -гликопротеида
DE1289809B (de) Verfahren zur Gewinnung von Urokinase fuer Injektionszwecke
JPS5265973A (en) Process for treating water containing phosphate and sulfate ions
GB1197415A (en) Process for the Purification of Reduced Pyridine Coenzymes
JPS5668690A (en) Method for concentration and purification of human fibroplastic interferon
JPS5668691A (en) Method for concentration and purification of human fibroplastic interferon
MORINO et al. Studies on the Heterotropic Interaction of Hemoglobin
JPH01235590A (ja) 赤血球由来Ｃｕ，Ｚｎ型スーパーオキシドジスムターゼ及びカタラーゼの製造方法